🇺🇸 FDA
Patent

US 7285639

Antibody to telomerase reverse transcriptase

granted A61KA61K38/00A61K39/00

Quick answer

US patent 7285639 (Antibody to telomerase reverse transcriptase) held by The Regents of the University of Colorado expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado
Grant date
Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K39/00, A61K48/00